These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 26688893)

  • 21. In defence of the use of modern chemotherapy regimens for the treatment of patients with chronic lymphocytic leukaemia.
    Tam CS
    Intern Med J; 2009 Dec; 39(12):858-9. PubMed ID: 20233254
    [No Abstract]   [Full Text] [Related]  

  • 22. Chemoimmunotherapy for chronic lymphocytic leukemia. Author reply.
    Goede V; Fischer K; Hallek M
    N Engl J Med; 2014 Jun; 370(24):2348-9. PubMed ID: 24918383
    [No Abstract]   [Full Text] [Related]  

  • 23. U.S. Food and drug administration approval: obinutuzumab in combination with chlorambucil for the treatment of previously untreated chronic lymphocytic leukemia.
    Lee HZ; Miller BW; Kwitkowski VE; Ricci S; DelValle P; Saber H; Grillo J; Bullock J; Florian J; Mehrotra N; Ko CW; Nie L; Shapiro M; Tolnay M; Kane RC; Kaminskas E; Justice R; Farrell AT; Pazdur R
    Clin Cancer Res; 2014 Aug; 20(15):3902-7. PubMed ID: 24824310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High dose chlorambucil versus Binet's modified cyclophosphamide, doxorubicin, vincristine, and prednisone regimen in the treatment of patients with advanced B-cell chronic lymphocytic leukemia. Results of an international multicenter randomized trial. International Society for Chemo-Immunotherapy, Vienna.
    Jaksic B; Brugiatelli M; Krc I; Losonczi H; Holowiecki J; Planinc-Peraica A; Kusec R; Morabito F; Iacopino P; Lutz D
    Cancer; 1997 Jun; 79(11):2107-14. PubMed ID: 9179056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ofatumumab maintenance versus observation in relapsed chronic lymphocytic leukaemia (PROLONG): an open-label, multicentre, randomised phase 3 study.
    van Oers MH; Kuliczkowski K; Smolej L; Petrini M; Offner F; Grosicki S; Levin MD; Gupta I; Phillips J; Williams V; Manson S; Lisby S; Geisler C;
    Lancet Oncol; 2015 Oct; 16(13):1370-9. PubMed ID: 26377300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Obinutuzumab for chronic lymphocytic leukemia: promise of the first treatment approved with breakthrough therapy designation.
    Kakkar AK; Balakrishnan S
    J Oncol Pharm Pract; 2015 Oct; 21(5):358-63. PubMed ID: 24827578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Response to fludarabine in B-cell chronic lymphocytic leukemia patients previously treated with chlorambucil as up-front therapy and a CHOP-like regimen as second line therapy.
    Liso V; Molica S; Capalbo S; Pogliani E; Battista C; Broccia G; Montillo M; Cuneo A; Leoni P; Specchia G; Castoldi G
    Haematologica; 2001 Nov; 86(11):1165-71. PubMed ID: 11694402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of subsequent therapies in patients with chronic lymphocytic leukemia previously treated with prednisone and either cladribine or chlorambucil.
    Robak T; Blonski JZ; Kasznicki M; Góra-Tybor J; Dmoszyñska A; Skotñicki A
    Haematologica; 2005 Jul; 90(7):994-6. PubMed ID: 15996945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chlorambucil--still not bad: a reappraisal.
    Catovsky D; Else M; Richards S
    Clin Lymphoma Myeloma Leuk; 2011 Jun; 11 Suppl 1():S2-6. PubMed ID: 22035743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination therapy with ofatumumab and bendamustine in xenograft model of chronic lymphocytic leukaemia.
    Haskova Z; Whitacre MN; Dede KA; Lee JM; Trulli SH; Ciucci M; Toso JF; White JR; Jonak ZL
    Br J Haematol; 2012 Feb; 156(3):402-4. PubMed ID: 21848524
    [No Abstract]   [Full Text] [Related]  

  • 31. A challenge to the claims that fludarabine and cyclophosphamide is the new standard treatment for chronic lymphocytic leukaemia.
    Haines I; Elliott P; Stanley R
    Intern Med J; 2009 Apr; 39(4):269-71. PubMed ID: 19402870
    [No Abstract]   [Full Text] [Related]  

  • 32. Richter syndrome in chronic lymphocytic leukaemia manifesting only as tumorous hepatomegaly.
    Tadmor T; Bejar J; Attias D; Polliack A
    Br J Haematol; 2011 Oct; 155(2):135. PubMed ID: 21973072
    [No Abstract]   [Full Text] [Related]  

  • 33. Rituximab plus fludarabine and cyclophosphamide prolongs progression-free survival compared with fludarabine and cyclophosphamide alone in previously treated chronic lymphocytic leukemia.
    Robak T; Dmoszynska A; Solal-Céligny P; Warzocha K; Loscertales J; Catalano J; Afanasiev BV; Larratt L; Geisler CH; Montillo M; Zyuzgin I; Ganly PS; Dartigeas C; Rosta A; Maurer J; Mendila M; Saville MW; Valente N; Wenger MK; Moiseev SI
    J Clin Oncol; 2010 Apr; 28(10):1756-65. PubMed ID: 20194844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic lymphocytic leukaemia--moving towards cure?
    Hillmen P
    Lancet; 2010 Oct; 376(9747):1122-4. PubMed ID: 20888976
    [No Abstract]   [Full Text] [Related]  

  • 35. Purging with chlorambucil to prevent infusion-related reaction before obinutuzumab administration: A monocentric pilot experience.
    Autore F; Fresa A; Innocenti I; Tomasso A; Morelli F; Corbingi A; Sorà F; Laurenti L
    Hematol Oncol; 2019 Dec; 37(5):641-643. PubMed ID: 31604368
    [No Abstract]   [Full Text] [Related]  

  • 36. Movement toward optimization of CLL therapy.
    Rai KR; Barrientos JC
    N Engl J Med; 2014 Mar; 370(12):1160-2. PubMed ID: 24645950
    [No Abstract]   [Full Text] [Related]  

  • 37. Ofatumumab and its role as immunotherapy in chronic lymphocytic leukemia.
    Sandhu S; Mulligan SP
    Haematologica; 2015 Apr; 100(4):411-4. PubMed ID: 25828085
    [No Abstract]   [Full Text] [Related]  

  • 38. A phase I study of imatinib mesylate in combination with chlorambucil in previously treated chronic lymphocytic leukemia patients.
    Hebb J; Assouline S; Rousseau C; Desjardins P; Caplan S; Egorin MJ; Amrein L; Aloyz R; Panasci L
    Cancer Chemother Pharmacol; 2011 Sep; 68(3):643-51. PubMed ID: 21120481
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monoclonal antibodies in chronic lymphocytic leukemia.
    Ferrajoli A; Faderl S; Keating MJ
    Expert Rev Anticancer Ther; 2006 Sep; 6(9):1231-8. PubMed ID: 17020457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bendamustine plus alemtuzumab is safe and feasible treatment for fludarabine refractory chronic lymphocytic leukaemia (CLL).
    Hill BT; Caimi P; Kindwall-Keller T; Habecker B; Kalaycio M
    Br J Haematol; 2014 Jan; 164(2):297-9. PubMed ID: 24131326
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.